Country: United States
Language: English
Source: NLM (National Library of Medicine)
ISOPROPYL ALCOHOL (UNII: ND2M416302) (ISOPROPYL ALCOHOL - UNII:ND2M416302)
Jianerkang Medical Co., Ltd
Isopropyl Alcohol
Isopropyl Alcohol 70 mL in 100 mL
TOPICAL
OTC DRUG
Antiseptic USE For skin cleansing prior to injection. - with electrocautery procedures - In the eyes. If contact occurs,flush eyes with water
OTC monograph not final
ALCOHOL- ISOPROPYL ALCOHOL SWAB JIANERKANG MEDICAL CO., LTD ---------- ALCOHOL SWABSTICK ACTIVE INGREDIENT Isopropyl Alcohol 70% PURPOSE Antiseptic USES USE For skin cleansing prior to injection. WARNINGS For external use only. Flammable. Keep away from fire or flame. DO NOT USE with electrocautery procedures In the eyes. If contact occurs,flush eyes with water KEEP OUT OF REACH OF CHILDREN condition persists or gets worse or lasts for more than 72 hours DIRECTIONS Apply in a circular motion from injection site outward.Discard after singly use. STORAGE Store at room temperature 15°-30℃ 59°-86°F) INACTIVE INGREDIENTS Purified Water PACKAGE LABEL - PRINCIPAL DISPLAY PANEL ALCOHOL isopropyl alcohol swab PRODUCT INFORMATION PRODUCT TYPE HUMAN OTC DRUG ITEM CODE (SOURCE) NDC:34645-1042 ROUTE OF ADMINISTRATION TOPICAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRENGTH ISOPROPYL ALCOHOL (UNII: ND2M416302) (ISOPROPYL ALCOHOL - UNII:ND2M416302) ISOPROPYL ALCOHOL 70 mL in 100 mL INACTIVE INGREDIENTS INGREDIENT NAME STRENGTH WATER (UNII: 059QF0KO0R) Jianerkang Medical Co., Ltd PACKAGING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:34645- 1042-1 1 in 1 POUCH 06/11/2015 1 21 mL in 1 APPLICATOR; Type 0: Not a Combination Product MARKETING INFORMATION MARKETING CATEGORY APPLICATION NUMBER OR MONOGRAPH CITATION MARKETING START DATE MARKETING END DATE OTC Monograph Drug M003 06/11/2015 LABELER - Jianerkang Medical Co., Ltd (530968767) ESTABLISHMENT NAME ADDRESS ID/FEI BUSINESS OPERATIONS Jianerkang Medical Co., Ltd 530968767 manufacture(34645-1042) Revised: 10/2023 Read the complete document